23andMe+ Premium Membership Bundle - DNA Test (before You Buy See Important Test Info Below)

Source: 23andMe internal data.. 23andMe Claim Substantiation for "80% get genetically meaningful health info." Date range: August 2020 - August 2021. Kits may not be redistributed or resold. For use in the USA only - kits shipped or used outside the US will be invalidated and no refund will be provided. Your use of 23andMe is further subject to 23andMe's Privacy Statement. Before you can use 23andMe and see your reports, you must agree to 23andMe's Terms of Service and Membership Terms at the time of registration of your 23andMe kit. Terms apply. Once a 23andMe+ membership has ended, customer will lose access to 23andMe+ reports and features; customer will retain access to Health+Ancestry Service reports and features. com/test-info/pharmacogenetics/ Membership auto-renews at then-current rate, unless canceled in advance. For important information and limitations regarding Pharmacogenetics reports, visit 23andme. Making changes to your current regimen can lead to harmful side effects or reduced intended benefits of your medication, therefore consult with your healthcare professional before taking any medical action. The PGS test is not a substitute for visits to a healthcare professional. Warning: Test information should not be used to start, stop, or change any course of treatment and does not test for all possible variants that may affect metabolism or protein function. Results for SLCO1B1 and DPYD and certain CYP2C19 results should be confirmed by an independent genetic test prescribed by your own healthcare provider before taking any medical action. Our CYP2C19 Pharmacogenetics report provides certain information about variants associated with metabolism of some therapeutics and provides interpretive drug information regarding the potential effect of citalopram and clopidogrel therapy. It does not describe if a person will or will not respond to a particular therapeutic and does not describe the association between detected variants and any specific therapeutic. **23andMe PGS Pharmacogenetics reports: The 23andMe test uses qualitative genotyping to detect 3 variants in the CYP2C19 gene, 2 variants in the DPYD gene and 1 variant in the SLCO1B1 gene in the genomic DNA of adults from saliva for the purpose of reporting and interpreting information about the processing of certain therapeutics to inform discussions with a healthcare professional. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child's risk of developing a particular disease later in life. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. It is not intended to diagnose any disease. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. Health predisposition reports include both reports that meet FDA requirements for genetic health risks and reports which are based on 23andMe research and have not been reviewed by the FDA. * The 23andMe PGS test includes health predisposition and carrier status reports. Subject to 23andMe’s Terms of Service at 23andme.com/tos and Privacy Statement at 23andme.com/about/privacy. You decide what you want to learn and what you want to share. Your data is encrypted, protected, and under your control. Discovery should never come at the expense of privacy. PRIVATE AND PROTECTED: Know that you are in control of your DNA. Find out what makes you unique with personalized trait reports including taste and smell, ability to match musical pitch or hatred of the sound of chewing. The automatic Family Tree feature makes it easy to see your DNA relationships. Opt-in to DNA Relative Finder to find & connect with people who share your DNA. Research your ancestry faster & more efficiently. INCLUDES ANCESTRY SERVICE: Discover your ancestry composition & where in the world your DNA is from across 2750+ geographic regions. PLUS FULL HEALTH + ANCESTRY SERVICE: Learn how genetics can influence your chances of developing certain health conditions.* Find out if you’re a carrier for certain inherited conditions.* Get meaningful DNA insights about your well-being and how it can influence certain lifestyle choices. Learn how your DNA may impact the way your body processes certain medications.** Valid payment method required at kit registration. Receive personalized genetic reports Powered by 23andMe Research on heart health, anxiety, migraine & more. 1-year membership with access to 190+ reports and NEW FEATURES Health Tracks℠ and Health Action Plan - recommendations based on genetic and non-genetic data, including blood test data. PREMIUM REPORTS & FEATURES: Fuel your health journey with ongoing value. Before purchasing, review important information at 23andme.com/test-info/pharmacogenetics and 23andme.com/test-info. Please review important information about Pharmacogenetics*, Carrier Status* and Genetic Health Risk* reports. IMPORTANT: There is a lot to consider with genetic testing